AMPK Cancer Research Results
AMPK, adenosine monophosphate-activated protein kinase: Click to Expand ⟱
| Source: |
| Type: |
AMPK: guardian of metabolism and mitochondrial homeostasis; Upon changes in the ATP-to-AMP ratio, AMPK is activated. (AMPK) is a key metabolic sensor that is pivotal for the maintenance of cellular energy homeostasis. It is well documented that AMPK possesses a suppressor role in the context of tumor development and progression by modulating the inflammatory and metabolic pathways.
-Activating AMPK can inhibit anabolic processes and the PI3K/Akt/mTOR pathway reducing glycolysis shifting toward Oxidative Phosphorlylation.
AMPK activators:
-metformin or AICAR
-Resveratrol: activate AMPK indirectly
-Berberine
-Quercetin: may stimulate AMPK
-EGCG: thought to activate AMPK
-Curcumin: may activate AMPK
-Ginsenosides: Some ginsenosides have been associated with AMPK activation
-Beta-Lapachone: A natural naphthoquinone compound found in the bark of Tabebuia avellanedae (also known as lapacho or taheebo). It has been observed to activate AMPK in certain models.
-Alpha-Lipoic Acid (ALA): associated with AMPK activation
|
Cerv, Cervical Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
GLS↓, NADPH↓, ROS↑, TumCD↑, AMPK↑, Hif1a↓, GLUT1↓, GLUT3↓, HK2↓, PFK↓, PKM2↓, LDH↓, cMyc↓, BAX↓, cycD1/CCND1↓, PDH↓, ROS↑, Apoptosis↑, eff↑, ACLY↓, FASN↓, Bcl-2↓, Glycolysis↓,
tumCV↓, BAX↑, BID↑, BOK↑, APAF1↑, TNF-α↑, FasL↑, Fas↑, FADD↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, Mcl-1↓, NAIP↓, Bcl-2↓, CDK4↓, CycB/CCNB1↓, cycD1/CCND1↓, cycE1↓, TRAIL↑, p‑Akt↓, Akt↓, mTOR↓, PDK1↓, BAD↓, GSK‐3β↑, AMPK↑, p27↑, P53↑,
| - |
in-vitro, |
Nor, |
MRC-5 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
- |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
mTOR↓, AMPK↑, selectivity↑, ROS↑, selectivity↑, HO-1↓, *NRF2↑, NRF2↓, *HO-1↑,
| - |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Cerv, |
SiHa |
|
|
|
EMT↓, P70S6K↓, mTOR↓, PKM2↓, Warburg↓, AMPK↑,
SREBP1↓, TumCP↓, TumCD↑, AMPK↑, SREBP1↓, FASN↓, ACC↓,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
HO-1↓, 1, NRF2↓, 1, ROS↑, 3,
Mitochondria & Bioenergetics ⓘ
BOK↑, 1,
Core Metabolism/Glycolysis ⓘ
ACC↓, 1, ACLY↓, 1, AMPK↑, 5, cMyc↓, 1, FASN↓, 2, GLS↓, 1, Glycolysis↓, 1, HK2↓, 1, LDH↓, 1, NADPH↓, 1, PDH↓, 1, PDK1↓, 1, PFK↓, 1, PKM2↓, 2, SREBP1↓, 2, Warburg↓, 1,
Cell Death ⓘ
Akt↓, 1, p‑Akt↓, 1, APAF1↑, 1, Apoptosis↑, 1, BAD↓, 1, BAX↓, 1, BAX↑, 1, Bcl-2↓, 2, BID↑, 1, Casp3↑, 1, Casp7↑, 1, Casp8↑, 1, Casp9↑, 1, FADD↑, 1, Fas↑, 1, FasL↑, 1, Mcl-1↓, 1, NAIP↓, 1, p27↑, 1, TRAIL↑, 1, TumCD↑, 2,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
DNA Damage & Repair ⓘ
P53↑, 1,
Cell Cycle & Senescence ⓘ
CDK4↓, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 2, cycE1↓, 1,
Proliferation, Differentiation & Cell State ⓘ
EMT↓, 1, GSK‐3β↑, 1, mTOR↓, 3, P70S6K↓, 1,
Migration ⓘ
TumCP↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1,
Barriers & Transport ⓘ
GLUT1↓, 1, GLUT3↓, 1,
Immune & Inflammatory Signaling ⓘ
TNF-α↑, 1,
Drug Metabolism & Resistance ⓘ
eff↑, 1, selectivity↑, 2,
Clinical Biomarkers ⓘ
LDH↓, 1,
Total Targets: 59
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
HO-1↑, 1, NRF2↑, 1,
Total Targets: 2
Scientific Paper Hit Count for: AMPK, adenosine monophosphate-activated protein kinase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:29 Cells:% prod#:% Target#:9 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page